• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 100
  3. 101
  4. 102
  5. 103
  6. 104
  7. …
  • Is two months long enough to monitor for vaccine safety concerns?

    18 November, 2020

    Vaccine manufacturers must provide at least two months of safety data to the FDA...

    COVID-19

  • Tourists are buying fake COVID-19 test results on the black market to travel

    Brazil // United Kingdom // France // 18 November, 2020

    Forging or purchasing of COVID test results for the purposes of travel has been identified in several locations...

    COVID-19

  • Immunity to the coronavirus might last years, perhaps even decades

    18 November, 2020

    A new study suggests that immunity to COVID-19 might last years...

    COVID-19

  • Cuba leads race for Latin American coronavirus vaccine

    Cuba // 18 November, 2020

    Two experimental COVID-19 vaccines are undergoing trials in Cuba...

    COVID-19

  • The differing storage requirements of mRNA vaccines

    17 November, 2020

    The logistics of storing, distributing, and administering vaccines have becomes vitally important...

    COVID-19

  • Johnson & Johnson launch phase 3 vaccine trials

    17 November, 2020

    A second Phase 3 trial of the J&J experimental vaccine begins...

    COVID-19

  • Strategies for the UK to avoid repeated lockdowns: study

    United Kingdom // 16 November, 2020

    Strategies include controlling community transmission in educational settings and keeping public health messages clear and consistent...

    COVID-19

  • Lab study finds face shields block only 2% of coughed aerosols

    16 November, 2020

    In a laboratory study, researchers evaluated the effectiveness of various face coverings...

    COVID-19

  • WHO COVID operational update

    16 November, 2020

    WHO COVID-19 weekly operational update

    COVID-19

  • Manufacturing capacity limits the total number of doses available until 2024

    16 November, 2020

    Current models predict that there will not be enough vaccine to cover the world's population until 2024...

    COVID-19

  • The world is betting big on AstraZeneca

    16 November, 2020

    Of the 4.95 billion doses of COVID-19 vaccinations with firm orders...

    COVID-19

  • A billion doses of COVID-19 vaccine are already reserved

    16 November, 2020

    Higher-income countries have pre-ordered half of projected COVID-19 vaccine supply...

    COVID-19

  • Analysis of COVID-19 second wave in Europe - highest incidence in young adults

    15 November, 2020

    Highest incidence of cases in adults aged 18-29 years...

    COVID-19

  • Interferon Beta Shows Positive Results from Phase II of SG016 Trial

    United Kingdom // 14 November, 2020

    Interferon Beta may be effective treatment…

    COVID-19

  • WHO: First-ever vaccine listed under emergency use, for polio

    13 November, 2020

    For the first time, WHO has granted a vaccine listing as...

    General Articles

  • D614G variant of SARS-CoV-2 shows efficient replication

    13 November, 2020

    The effect of this variant on vaccine efficacy has been of concern...

    COVID-19

  • Ultrasound imaging shows acute testicular infection in COVID-19 patients

    13 November, 2020

    Risk of infection increases with age...

    COVID-19

  • CDC: Passenger entry screening at airports ineffective and resource-intensive

    13 November, 2020

    Passenger entry screening at airports for COVID-19 symptoms was ineffective

    COVID-19

  • Airborne SARS-COV-2 virus particles found up to 50m in a hospital ventilation system

    13 November, 2020

    A study from Sweden investigated the potential of long-distance aerosol transmission of SARS-CoV-2 in a hospital setting...

    COVID-19

  • SARS-CoV-2 can remain infectious on skin for up to 4 days

    13 November, 2020

    A study has found that SARS-CoV-2 can remain infectious on skin for up to 96 hours (4 days) under laboratory conditions...

    COVID-19

  1. …
  2. 100
  3. 101
  4. 102
  5. 103
  6. 104
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS